Recombinant BPI Protein, Human (His Tag) Recombinant Proteins The human BPI (P17213) (Met1-Lys487) with a C-terminal polyhistidine tag was expressed The recombinant human BPI comprises 467a.a and has a predicted molecular weight of 52.1 kDa.
$ $99 In stock
Formulation: The recombinant human BPI comprises 467a.a and has a predicted molecular weight of 52.1 kDa.
Source: HEK293 Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant BPI Protein, Human (His Tag)

Formulation: Recombinant BPI Protein was lyophilized from sterile PBS, pH 7.41

Source: HEK293 Cells

Product Name Recombinant BPI Protein, Human (His Tag)
Product Type Recombinant Protein
Source HEK293 Cells
Formulation Recombinant BPI Protein was lyophilized from sterile PBS, pH 7.41
Molecular Weight The recombinant human BPI comprises 467a.a and has a predicted molecular weight of 52.1 kDa.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method
Purity Greater than 85% as determined by SDS-PAGE
Description The human BPI (P17213) (Met1-Lys487) with a C-terminal polyhistidine tag was expressed
Host Species Homo sapiens (Human)
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Met1-Lys487
Product Background Bactericidal/permeability-increasing protein is a member of the BPI/LBP/Plunc superfamily and BPI/LBP family. It is a cationic protein which can be detected in the azurophilic granule and on the surface of polymorphonuclear leukocytes. Bactericidal/permeability-increasing protein also is a lipopolysaccharide binding protein. It is associated with human neutrophil granules and has bactericidal activity on gram-negative organisms. Bactericidal/permeability-increasing protein contains two domains that adopt the same structural fold, even though they have little sequence similarity. It binds to and neutralises lipopolysaccharides from the outer membrane of Gram-negative bacteria. The cytotoxic action of bactericidal/permeability-increasing protein is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope.
Memo BPIFD1 Protein, Human;rBPI Protein, Human
Uniprot Number P17213
Terminal Val 32
Bioactivity Please contact us for detailed information